Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review
This case report highlights the complexity of managing ROP, particularly for recurrent ROP in very low birth weight infants. Premature infants with extremely low birth weight may benefit from a repeat injection of anti-VEGF after the initial IVB to treat the recurrence.
Authors
- K V Chalam (ORCID: https://orcid.org/0000-0002-0004-9416)
- Elizabeth Yang (ORCID: https://orcid.org/0000-0002-7711-9371)
- David T.Y. Yang
- Samarth P. Shah (ORCID: https://orcid.org/0000-0001-9890-8858)
- Anny M. S. Cheng (ORCID: https://orcid.org/0000-0001-7035-8567)
- Timothy J. Steiner (ORCID: https://orcid.org/0000-0002-1882-4337)
- Neil E. Kanterman
Institutions
- National Taiwan University (TW)
- Historic Deerfield (US)
- University of Florida (US)
- Florida Cancer Care (US)
- Broward Health (US)
- New York University (US)
- New York College of Health Professions (US)
- Northeast Ohio Medical University (US)
Publication Details
- Journal
- Case Reports in Ophthalmology
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1159/000546935
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00